Schedule 13D - Activist Investments
NYSE
Key executives G.V. Prasad and K. Satish Reddy transferred significant shareholdings into family trusts for estate planning and succession, following a 1:5 stock split.
Schedule 13G - Passive Investments
NYSE
SCHEDULE 13G/A: BlackRock Amends Stake in Dr. Reddy's Laboratories, Reports 4.1% Beneficial Ownership
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 4.1% beneficial ownership stake in Dr. Reddy's Laboratories Ltd. as of March 31, 2025.